Jakarta, January 15, 2025 – SIG has once again demonstrated its commitment to supporting the growth of Indonesia’s medical device industry by participating as a sponsor in the National Conference (Munas) of the Indonesian Medical Device Manufacturers Association (ASPAKI) 2025. The conference, held at the Bidakara Hotel in Jakarta, served as an important moment to strengthen synergy between the government, the industry, and other stakeholders in promoting national medical device independence.
The event was opened by ASPAKI Chairperson for 2021-2024, Imam Subagyo, and inaugurated by the Chairman of the National Economic Council, General (HOR) Luhut Binsar Pandjaitan, MPA. Also in attendance were the Director General of Metal, Machinery, Transportation Equipment, and Electronics Industries (Ilmate) of the Ministry of Industry, Dr. Setia Diarta, MT., and the Director General of Pharmaceuticals and Medical Devices of the Ministry of Health, Dr. Dra. Lucia Rizka Andalusia, Apt., M.Pharm., MARS. The conference was attended by over 160 medical device manufacturers under ASPAKI, which represents 225 domestic medical device companies.
ASPAKI’s Commitment and Enhancing Competitiveness of National Medical Devices
In his speech, Imam Subagyo expressed hopes that the medical device industry would grow by 8% in 2025, aligning with the government’s optimism for national economic prospects. “We are fully committed to supporting this growth through collaboration with various parties, including associations, educational institutions, and research bodies. Additionally, we are focusing on introducing domestic medical devices to the global market,” said Imam.
The 3rd ASPAKI National Conference also marked the organization’s 27th anniversary in August 2025. ASPAKI’s achievements in promoting local products at international forums have demonstrated that Indonesian medical devices are highly competitive. The conference agenda included management reports, discussions on current issues such as e-catalog version 6 and Local Content Requirements (TKDN), as well as the election of the ASPAKI Chairperson for the 2025-2027 term.
The Chairman of the National Economic Council, Luhut Binsar Pandjaitan, emphasized the importance of supporting domestic medical devices to reduce dependence on imports. “Indonesia has raw materials such as nickel and stainless steel. We no longer need to import simple devices from abroad. Let’s innovate and focus on improving the quality of local products,” Luhut stressed.
Additionally, Luhut highlighted the importance of the quality of domestic products as a prerequisite for supporting exports, particularly to potential markets like Africa. “Africa is highly interested in our technology, which, although not overly sophisticated, fits their needs. This is a great opportunity,” he added.
A SIG representative together with the Chairman of the Economic Council touring the exhibition booth and engaging in discussions
SIG’s Strategic Role in Supporting the Medical Device Industry
With its extensive experience and strong reputation in testing and development, SIG plays a strategic role as a partner for medical device manufacturers and the government. SIG not only provides testing services but also offers solutions and advice for advancing the domestic medical device industry.
Amid growing attention to TKDN and opportunities for expansion into African markets, SIG is ready to collaborate on various development initiatives. “SIG is committed to supporting medical device manufacturers in improving the quality and competitiveness of local products. Through innovation and collaboration, we believe Indonesia’s medical device industry can grow rapidly and make significant contributions to domestic production independence,” said a SIG representative.
SIG welcomes the recommendations from the ASPAKI 2025 National Conference, including strategies for increasing TKDN. With its expertise, SIG can help manufacturers meet international quality standards and access global markets. For example, the African market presents a significant opportunity to export local products tailored to their needs.
SIG’s services to support the advancement of medical devices include the following tests:
- Cytotoxicity Testing
- Skin Sensitization Testing
- Single & Repeated Dermal Irritation Testing
- Mucosal Irritation Testing (Eyes & Vaginal)
- Intradermal Reactivity Testing
- Pyrogen/Material Mediator Testing
- Acute Systemic Toxicity Testing
- Subacute/Subchronic Systemic Toxicity Testing
- Chronic Systemic Toxicity Testing
- Endotoxin Testing
- Sterility Testing
- Needle Sharpness Testing
- Cotton Absorbency Testing
- Bisphenol A Residual Testing
- Fumigant Residue Testing (EtO), and
- Medical Mask Testing
The SIG booth is being visited by several Munas participants
Collaboration for the Future of the Medical Device Industry
SIG’s support for the ASPAKI 2025 National Conference reflects the company’s tangible commitment to advancing the health sector in Indonesia. Through collaboration with ASPAKI and the government, SIG aims not only to strengthen the domestic medical device sector but also to support innovation and product development oriented toward global needs.
Amid challenges such as price anomalies in e-catalogs and import dependency, SIG believes that synergy between the government, industry players, and society is the key to creating a sustainable ecosystem. With this approach, SIG hopes to contribute to building a self-reliant and competitive medical device industry, both nationally and internationally.
Closing
SIG’s participation in the ASPAKI 2025 National Conference demonstrates the company’s ongoing commitment to supporting the growth and independence of Indonesia’s medical device industry. Through strategic collaboration, innovation, and quality improvement of local products, SIG is optimistic that this sector can positively impact public health and the national economy. Together, let us build a better future for Indonesia’s medical device industry.
As a trusted laboratory, SIG is dedicated to advancing the medical device industry by being a reliable testing partner for manufacturers and the government. For more information about our testing services, contact us at 082111516516, visit our official website at siglaboratory.com, or come directly to Graha SIG, Jl Rasamala No. 20, Taman Yasmin, Bogor, Jawa Barat 16113.
EN 
ID